ANTX — AN2 Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareSmall Cap
- $81.57m
- -$25.72m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.6 | 4.07 | 58.6 | 96.1 | 107 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.7 | 4.23 | 60.1 | 98.6 | 111 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 5.7 | 4.23 | 65.3 | 103 | 139 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.159 | 1.46 | 3.4 | 7.19 | 14 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.887 | 1.48 | 3.41 | 7.19 | 14 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 4.81 | 2.75 | 61.9 | 95.4 | 125 |
Total Liabilities & Shareholders' Equity | 5.7 | 4.23 | 65.3 | 103 | 139 |
Total Common Shares Outstanding |